Policy changes Backwork has recorded, newest first. The most recent change on record is from October 11, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
82,244 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 22, 2026 | Independence Blue Cross | Talquetamab-tgvs (Talvey) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Tafasitamab-cxix (Monjuvi) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Sutimlimab-jome (Enjaymo) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Spesolimab-sbzo (Spevigo) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Secukinumab (Cosentyx) for Intravenous Use | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Sacituzumab govitecan-hziy (Trodelvy) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Rozanolixizumab-noli (Rystiggo) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Rituximab (Rituxan) Infusion and Related Biosimilars, and Rituximab/Hyaluronidase Human for Subcutaneous Injection (Rituxan Hycela) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Risankizumab-rzaa (Skyrizi) for Intravenous Use | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Repository Corticotropin Injection (Acthar Gel, Purified Cortrophin Gel) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Ramucirumab (Cyramza) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Polatuzumab vedotin-piiq (Polivy) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Photodynamic Therapy (PDT) Using Verteporfin (Visudyne) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Photodynamic Therapy (PDT) Using Levulan Kerastick or Ameluz (Aminolevulinic Acid HCl [ALA]) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Pharmacogenetics and Metabolite Monitoring for Using Azathioprine (AZA)/6-Mercaptopurine (6-MP) Therapy (Independence Administrators) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf (Phesgo) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Pertuzumab (Perjeta) and related biosimilar pertuzumab-dpzb (Poherdy) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Personalized Vaccines (e.g., Provenge) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Pemetrexed (Pemfexy) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Pembrolizumab and berahyaluronidase alfa-pmph (Keytruda QLEX) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Pembrolizumab (Keytruda) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Pegloticase (Krystexxa) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Patisiran (Onpattro) and vutrisiran (Amvuttra) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)/(Abraxane for Injectable Suspension) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Omalizumab (Xolair) and related biosimilars | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | olipudase alfa-rpcp (Xenpozyme) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Octreotide Acetate (Sandostatin LAR Depot) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Ocrelizumab (Ocrevus) and Ocrelizumab and Hyaluronidase-ocsq (Ocrevus Zunovo) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Nogapendekin alfa inbakicept-pmln (Anktiva) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Nivolumab and Relatlimab-rmbw (Opdualag) for intravenous use | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Nivolumab (Opdivo), Nivolumab and Hyaluronidase-nvhy (Opdivo Qvantig) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Nipocalimab-aahu (Imaavy) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Natalizumab (Tysabri) and Related Biosimilars | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Nadofaragene Firadenovec-vncg (Adstiladrin) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Mosunetuzumab-axgb (Lunsumio) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Mogamulizumab-kpkc (Poteligeo) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Mirvetuximab soravtansine-gynx (Elahere) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Margetuximab-cmkb (Margenza) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Luspatercept–aamt (Reblozyl) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Lurbinectedin (Zepzelca) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Lumasiran (Oxlumo) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Loncastuximab tesirine-lpyl (Zynlonta) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | linvoseltamab-gcpt (Lynozyfic) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Leuprolide (Camcevi, Camcevi ETM, Eligard, Fensolvi, Lupron Depot) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Lanreotide (Somatuline Depot) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Isatuximab-irfc (Sarclisa) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Ipilimumab (Yervoy) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Intravenous Infliximab and Related Biosimilars | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Interleukin-5 (IL-5) Antagonist (e.g., Cinqair, Exdensur) | Codes changed |
| Aug 22, 2026 | Independence Blue Cross | Inebilizumab-cdon (Uplizna) | Codes changed |